This JAMA Forum discusses the cost of newly approved weight loss medications in the US compared with other countries and provides arguments for why these medications should be more available for individuals in the US and covered by more insurers.
No takes yet. Share an insight, caveat, or question.
David Cutler (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: